UPDATE : Thursday, March 22, 2018
Anticoagulant latecomer Lixiana outrivals Eliquis
The competition between No.2 and No.3 next-generation anticoagulant is heat...
by So Jae-hyeon  |  2018-03-22 16:12
Yuyu to start clinical trials on dry eye treatment
Yuyu Pharmaceuticals said Thursday that it has received approval from the M...
by Lee Han-soo  |  2018-03-22 14:34
Daewoong to promote AstraZeneca’s diabetes treatment
Daewoong Pharmaceutical and AstraZeneca Korea have signed a co-promotion pa...
by Lee Han-soo  |  2018-03-22 11:25
Daiichi Sankyo Korea to co-market Kuhnil’s dyslipidemia treatment
Daiichi Sankyo Korea said Thursday that it has signed a strategic partnersh...
by Lee Han-soo  |  2018-03-22 11:25
European urology group praises Gemvax & KAEL’s research paper
Gemvax & KAEL said Wednesday that the European Association of Urology (EAU)...
by Lee Han-soo  |  2018-03-22 11:24
Roche’s Tecentriq gets reimbursement as 2nd line treatment for 2 cancers
Roche Korea (CEO: Matt Sause) said Wednesday that the country’s first anti ...
by Marian Chu  |  2018-03-21 18:27
JW Pharma gets orphan drug status for Roche’s hemophilia treatment
JW Pharmaceutical said Wednesday that the Ministry of Food and Drug Safety ...
by Lee Han-soo  |  2018-03-21 15:47
Daewoong promotes botulinum toxin Nabota in Dubai
Daewoong Pharmaceutical has begun pushing international marketing activitie...
by So Jae-hyeon  |  2018-03-21 15:47
Genexine gets FDA nod for trials on immunotherapeutic agent
Genexine said Tuesday that it has received approval to go ahead with the ph...
by Lee Han-soo  |  2018-03-21 11:40
4 drugmakers’ profits turn to losses
Among KOSDAQ-listed pharmaceutical companies, four firms’ operating profits...
by Nam Doo-hyun  |  2018-03-21 11:38
Merck Korea says study confirms safety, efficacy of heart drug in Asian patients
Merck Biopharma Korea said that its coronary heart disease drug Concor (bis...
by Marian Chu  |  2018-03-20 19:42
Genexine’s clinical trial on persistent growth hormone running smoothly
Genexine and Handok have announced the intermediate results of phase 2 clin...
by Lee Han-soo  |  2018-03-20 16:19
What will be 1st approved stem cell treatment this year?
Domestic companies are rolling out developments on stem cell treatments, le...
by So Jae-hyeon  |  2018-03-20 11:34
World’s top painkiller Advil underperforms in Korea
Advil, the world’s best-selling pain reliever, is not performing well in Ko...
by So Jae-hyeon  |  2018-03-20 11:16
Novartis says global guideline recommends its hives therapy
Novartis Korea said Monday that the National Center for Biotechnology Infor...
by Marian Chu  |  2018-03-19 17:36
Godex tops prescription liver drug in sales
Celltrion Pharm’s Godex, a prescription treatment for liver disease, won th...
by So Jae-hyeon  |  2018-03-19 15:47
Ahngook unveils research results for cough treatment
Ahngook Pharmaceutical announced Monday that Ivy leaf and Rhodiola, the mai...
by Lee Han-soo  |  2018-03-19 15:02
Will SK Chemicals get more reimbursement for Parkinson’s disease drug?
Whether SK Chemicals will get expanded insurance coverage for its newly imp...
by So Jae-hyeon  |  2018-03-19 14:24
GemVax & KAEL’s tracer proves radioprotective, anti-fibrotic effects
GemVax & KAEL announced Thursday that its GV1001 has demonstrated radioprot...
by Lee Han-soo  |  2018-03-16 16:02
Seoul's antismoking policy mainly benefits multinational pharma firms
Multinational pharmaceutical companies benefited from the Korean government...
by So Jae-hyeon  |  2018-03-15 15:47
Back to Top